Pular para o conteúdo principal
Ranking Invest

PRTA - Prothena Corporation plc

Segmento: HealthcareProthena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a humanized monoclonal antibody, which is in Phase IIb clinical trial for the treatment of Parkinson's disease; PRX004 that completed Phase I clinical trial for the treatment of Transthyretin amyloidosis; and PRX005, which is in Phase I clinical trial for the treatment of Alzheimer's disease. Its discovery and preclinical programs include PRX012 for the treatment of Alzheimer's disease; and dual Aß-Tau vaccine for the treatment and prevention of Alzheimer's disease. Prothena Corporation plc has a license, development, and commercialization agreement with F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. to develop and commercialize antibodies that target alpha-synuclein; and a collaboration agreement with Bristol-Myers Squibb to develop antibodies. The company was founded in 2012 and is based in Dublin, Ireland.

Análise Ranking Invest

Valor de Mercado
$ 431.23 Mi
IVR
-0.41Índice proprietário de comparação relativa: -0,41.
IVR2
-1.14Leitura proprietária complementar: -114%.
MLL
-1.14Leitura proprietária complementar: -114%.
Último Balanço Atualizado: 2T2026

O Ranking Invest utiliza metodologia proprietária baseada em dados financeiros públicos; fórmulas e valores intermediários são confidenciais.

Dados da Empresa

Patrimônio Líquido

$ 286.89 Mi

Dívida Líquida

-$ 288.19 Mi

L4T

-$ 43.99 Mi

MM4T

-26523.42%

Indicadores Básicos

ROE

-15.33%

Índices de Previsibilidade

Receita Líquida

G1.36

Lucro

E1.07

Margem

E1.28

Índices de Tendência

Receita Líquida

D-1.53

Lucro

D0.20

Margem

E-3.64

Índices de Endividamento

DIV/PAT

-1.00

DIV/L4T

6.55

Dívidas
Cotação
Gráfico Lucro/Receita Líquida X TrimestrePor padrão são exibidos os últimos 16 trimestres; quando houver mais trimestres disponíveis, use o botão junto à tabela de resultados para expandir o histórico.